Biotech news
Americas
The US Food and Drug Administration approved Sandoz’s cancer product Zarxio on Friday—the first biosimilar to be rubber stamped in the US. 9 March 2015
Americas
Law firm Fried, Frank, Harris, Shriver & Jacobson has added a life sciences specialist to its intellectual property litigation practice. 5 March 2015
Americas
The US Patent and Trademark Office’s Patent Trial and Appeal Board has handed down what are thought to be the first written decisions in inter partes review proceedings that concern the biopharmaceutical industry. 5 March 2015
Americas
Life sciences lawyer Lana Gladstein has joined US law firm Nutter McClennen & Fish’s intellectual property practice as partner. 4 March 2015
Americas
The FDA could approve the US’s first biosimilar product any day now. But is the country ready for the wave of biosimilar applications that
will surely follow, and how quickly can these cut-price drugs come to market? LSIPR reports. 3 March 2015
Biotech
The patentability of human embryonic stem cells is bound up with many ethical considerations, including the viability of the cells used. Laura von Hertzen and Robert Burrows of Bristows discuss the latest legal opinions. 3 March 2015
Americas
Genetically modified plants, hybrid seeds and plants obtained from such seeds are usually granted patent protection in Mexico as they are not created by ‘essentially biological’ processes, as Fernando Rincón of Becerril, Coca & Becerril reports. 3 March 2015
Biotech
Controversial patents covering a fruit and a vegetable are awaiting their fate at the Enlarged Board of Appeal. LSIPR examines the likelihood of their succeeding. 3 March 2015
Americas
Law firm Kaye Scholer has added a team of three life sciences and technology lawyers to its intellectual property group. 13 February 2015
Americas
Existing portfolios should be carefully reviewed and care must be taken in drafting new patent applications to withstand section 101 scrutiny in the US, as Judith Kim, director, and Scott Schaller, of counsel, at Sterne Kessler Goldstein & Fox, describe. 30 January 2015